Neurotoxicity can occur after exposure to natural or artificial molecules that alter the normal function of the nervous system. The review article by R. Lugo-Huitrón et al. focuses on the toxicity of quinolinic acid, an endogenous metabolite of the kynurenine pathway, normally present in the brain and cerebrospinal fluid. This paper discusses the different mechanisms by which quinolinic acid acts as a neurotoxin, such as the activation of N-methyl-D-aspartate (NMDA) receptors, mitochondrial dysfunction, oxidative stress, inflammation, and cell death. In an opinion paper A. Bayot and P. Rustin present arguments in favor of the hypothesis that the reduction in the expression of PIP5K1B, the gene adjacent to the frataxin-encoding gene, in Friedreich's ataxia patient cells is implicated in disease onset and progression.
The antioxidant effect of numerous phytochemicals has long been recognized and has been proposed as an alternative form of treatment, since still no drugs are available that prevent the progression of most neurodegenerative diseases. In an original article, H. Mo et al. describe the potential neuroprotective effect of tea polyphenols in an in vivo subarachnoid hemorrhage mice model. A. Tarozzi et al. present a review of the antioxidant properties of sulforaphane primarily attributed to its ability to activate the Nrf2/ARE pathway.
We believe that these contributions provide an updated view on this dynamic field and evidence that supports the importance of considering oxidative stress as a player in neurodegenerative diseases as well as neurotoxicity.
